Whoop, a screen-free wearable health monitoring company, has raised $575M in Series G funding led by Collaborative Fund. The platform tracks sleep, strain, recovery, stress, heart health, and more via devices like WHOOP 5.0 with medical-grade sensors and integrates 65+ blood biomarkers through Advanced Labs. The capital will fuel hiring over 600 roles, R&D for preventive health features, and international expansion.
Screenless Wearables Spark Funding Surge
The round values Whoop at $10.1B post-money, nearly tripling its prior $3.6B valuation, amid a wave of activity in recovery-focused wearables. Rival Oura has raised $1.25B total with recent rounds pushing toward IPO talks at ~$11B valuation. Google readies a screenless Fitbit band to challenge Whoop's model per Bloomberg. Whoop's subscription-driven AI coaching differentiates in this crowded space.
Reactive Healthcare Misses Prevention Window
Healthcare systems remain reactive, while 80% of chronic diseases are preventable through proactive monitoring. Americans spend 15% of life with disease, rising to 85% over age 65 having chronic conditions. Wearables like Whoop shift focus to healthspan—tracking biological age versus chronological age—to extend healthy years.
Advanced Labs Fuse Wearable and Blood Data
Whoop's ecosystem combines always-on sensors for strain, recovery, and HRV with Advanced Labs analyzing 65+ biomarkers from Quest Diagnostics uploads. AI coaching delivers personalized plans, including women's hormonal insights from 45,000 cycles across 11,000+ members. Unlike ring-focused rivals emphasizing sleep, Whoop prioritizes athlete-grade strain and musculoskeletal load metrics.
As Will Ahmed, Founder & CEO noted:
"I do envision the potential of Whoop to predict that you’re going to have a heart attack before you do."
Sovereign Funds Back Global Scaling
Collaborative Fund and Foundry Group—prior Whoop investors—led alongside Qatar Investment Authority, Mubadala, Abbott, and Mayo Clinic. Strategic health giants signal validation for medical-grade expansions like ECG and AFib detection. Athlete investors including Cristiano Ronaldo and LeBron James underscore elite performance credibility.
Fitness Trackers Eye $163B Horizon
The fitness tracker market stands at $60.9B in 2024, projected to reach $162.8B by 2030 at 18% CAGR per Grand View Research. Competitors like Ultrahuman ($60M raised) offer no-subscription rings, while established players like Polar launch screenless bands. Whoop's $1.1B bookings run rate, up 103% YoY, and 2.5M members position it for leadership amid big tech entry.
Solo Founder Scales to Decacorn
Will Ahmed, a former Harvard athlete, founded Whoop after personal overtraining experiences, drawing from 500+ medical papers on HR/HRV. As a first-time founder, he has raised over $900M total to $10.1B valuation with PhD-backed research teams. Recent hires in AI, biomedical engineering, and medicine bolster advanced features.
Hiring Surge Targets Global Markets
Whoop plans to add 600+ roles—a 75% headcount increase—for engineering, research, and operations. Expansion targets Europe, GCC, Latin America, and Asia, building on partnerships like PGA TOUR (to 2028) and Premier Padel. Cash flow positive in 2025, the firm eyes IPO preparation through "no-regrets" public company work.